China National Biotec Group and Guangzhou Laboratory sign a patent transfer agreement for a combined respiratory vaccine.

According to China National Biotec Group, on September 29, Sinopharm Group China National Biotec Group signed a patent transfer agreement for a combined respiratory vaccine with the Guangzhou Laboratory. The two parties will carry out in-depth cooperation on process development and industrial application of innovative antigens for the combined respiratory vaccine.